GR3017672T3 - Therapeutic agent for diabetic gangrene. - Google Patents

Therapeutic agent for diabetic gangrene.

Info

Publication number
GR3017672T3
GR3017672T3 GR950402776T GR950402776T GR3017672T3 GR 3017672 T3 GR3017672 T3 GR 3017672T3 GR 950402776 T GR950402776 T GR 950402776T GR 950402776 T GR950402776 T GR 950402776T GR 3017672 T3 GR3017672 T3 GR 3017672T3
Authority
GR
Greece
Prior art keywords
therapeutic agent
diabetic gangrene
gangrene
diabetic
agent
Prior art date
Application number
GR950402776T
Other languages
English (en)
Inventor
Masahiko Shikano
Satoshi Tanaka
Masao Ikdea
Hiroshi Nin
Original Assignee
Hoechst Japan
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoechst Japan filed Critical Hoechst Japan
Publication of GR3017672T3 publication Critical patent/GR3017672T3/el

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/36—Blood coagulation or fibrinolysis factors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2/00—Methods or apparatus for disinfecting or sterilising materials or objects other than foodstuffs or contact lenses; Accessories therefor
    • A61L2/0005—Methods or apparatus for disinfecting or sterilising materials or objects other than foodstuffs or contact lenses; Accessories therefor for pharmaceuticals, biologicals or living parts
    • A61L2/0011—Methods or apparatus for disinfecting or sterilising materials or objects other than foodstuffs or contact lenses; Accessories therefor for pharmaceuticals, biologicals or living parts using physical methods
    • A61L2/0023—Heat
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43—Enzymes; Proenzymes; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/10—Transferases (2.)
    • C12N9/1025—Acyltransferases (2.3)
    • C12N9/104—Aminoacyltransferases (2.3.2)
    • C12N9/1044—Protein-glutamine gamma-glutamyltransferase (2.3.2.13), i.e. transglutaminase or factor XIII
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Diabetes (AREA)
  • Zoology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Biomedical Technology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Wood Science & Technology (AREA)
  • Hematology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Immunology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Obesity (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Emergency Medicine (AREA)
  • Endocrinology (AREA)
  • Dermatology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
GR950402776T 1990-02-20 1995-10-06 Therapeutic agent for diabetic gangrene. GR3017672T3 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2037284A JPH03240738A (ja) 1990-02-20 1990-02-20 糖尿病性壊疽治療剤
EP91102606A EP0499679B1 (en) 1990-02-20 1991-02-22 Therapeutic agent for diabetic gangrene

Publications (1)

Publication Number Publication Date
GR3017672T3 true GR3017672T3 (en) 1996-01-31

Family

ID=40202967

Family Applications (1)

Application Number Title Priority Date Filing Date
GR950402776T GR3017672T3 (en) 1990-02-20 1995-10-06 Therapeutic agent for diabetic gangrene.

Country Status (13)

Country Link
US (1) US5164373A (el)
EP (1) EP0499679B1 (el)
JP (1) JPH03240738A (el)
KR (1) KR0184008B1 (el)
AT (1) ATE128358T1 (el)
AU (1) AU647078B2 (el)
CA (1) CA2036592C (el)
DE (1) DE69113437T2 (el)
DK (1) DK0499679T3 (el)
ES (1) ES2077698T3 (el)
GR (1) GR3017672T3 (el)
IE (1) IE69393B1 (el)
PT (1) PT96828B (el)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP3337488B2 (ja) * 1992-03-06 2002-10-21 アベンティス ファーマ株式会社 切迫流産治療剤
DE19508192A1 (de) * 1995-03-09 1996-09-12 Behringwerke Ag Stabile Transglutaminasepräparate und Verfahren zu ihrer Herstellung
EP1507543A4 (en) * 2002-05-09 2006-07-26 Cambridgemed Inc PHARMACEUTICAL COMPOSITION FOR THE TREATMENT OF WOOD WITH BLOOD PLASMA OR SERUM
PL2268267T3 (pl) * 2008-04-21 2017-12-29 Novo Nordisk Health Care Ag Kompozycja sucha transglutaminazy

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3904751A (en) * 1970-12-22 1975-09-09 Behringwerke Ag Process for isolating a fibrin stabilizing factor from human placenta
US3931399A (en) * 1970-12-22 1976-01-06 Behringwerke Aktiengesellschaft Process for isolating a fibrin-stabilizing factor
JPS6029687B2 (ja) * 1978-11-07 1985-07-12 株式会社ミドリ十字 ヒト胎盤由来血液凝固第１０３因子の濃縮液の製造方法
DE2916711A1 (de) * 1979-04-25 1980-11-06 Behringwerke Ag Blutgerinnungsfaktoren und verfahren zu ihrer herstellung
JPS56135418A (en) * 1980-03-27 1981-10-22 Green Cross Corp:The Heat treatment of aqueous solution containing 8 factor of coagulation of blood derived from human
DE3419581A1 (de) * 1984-05-25 1985-11-28 Behringwerke Ag, 3550 Marburg Verfahren zur gewinnung einer faktor xiii-praeparation sowie ihre verwendung
JPS63196520A (ja) * 1987-02-09 1988-08-15 Hoechst Japan Kk 潰瘍性大腸炎治療剤
US4904751A (en) * 1987-12-21 1990-02-27 Texaco Chemical Company N,N'-dialkyl substituted polyoxyalklene amines as curing agents for blocked isocyanates
AT397203B (de) * 1988-05-31 1994-02-25 Immuno Ag Gewebeklebstoff
DE3829524A1 (de) * 1988-08-31 1990-03-01 Behringwerke Ag Verwendung von transglutaminasen als immunsuppressiva

Also Published As

Publication number Publication date
CA2036592C (en) 2004-04-06
DK0499679T3 (da) 1996-02-05
EP0499679B1 (en) 1995-09-27
JPH03240738A (ja) 1991-10-28
PT96828A (pt) 1991-11-29
IE910565A1 (en) 1991-08-28
CA2036592A1 (en) 1991-08-21
EP0499679A1 (en) 1992-08-26
DE69113437T2 (de) 1996-04-11
IE69393B1 (en) 1996-09-18
KR0184008B1 (ko) 1999-05-01
AU647078B2 (en) 1994-03-17
US5164373A (en) 1992-11-17
ATE128358T1 (de) 1995-10-15
ES2077698T3 (es) 1995-12-01
KR910021244A (ko) 1991-12-20
PT96828B (pt) 1998-07-31
AU7117891A (en) 1991-08-22
JPH0561253B2 (el) 1993-09-06
DE69113437D1 (de) 1995-11-02

Similar Documents

Publication Publication Date Title
AU3275689A (en) Process for stabilizing human albumin solutions and the solution obtained
AU549481B2 (en) Hair growing agent
NO171365C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive benzimidazolderivater
NO166448C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive tiazolidindioner.
GR3023825T3 (en) Benzopyran derivatives, processes for their preparation and their use and preparations containing the compounds
NO890259D0 (no) Fremgangsmaate for fremstilling av terapeutisk aktive etylfenoksyacetamider.
ATE97813T1 (de) Mittel zur kontrolle von thrombenbildungen.
AU1176688A (en) Method of treatment comprising transcutaneous administration of prostaglandin E1 derivatives
AU3024389A (en) Therapeutic agent for the prevention of intraventricular hemorrhage in premature infants
GR3017672T3 (en) Therapeutic agent for diabetic gangrene.
AU3401093A (en) Therapeutic agent for threatened abortion
HUT46214A (en) Process for producing medical preparation suitable for treatment of peptic ulcer
AU2443888A (en) Agents for treating high blood pressure and cardiac insufficiency
ATE56147T1 (de) T-pa enthaltende medizinische zubereitung und deren verwendung.
HUT63441A (en) Megakariocyte colony stimultating factor protein
DE3883044D1 (de) Wirkstoff zur tumorbekaempfung.
ATE126437T1 (de) Verwendung von depogen zur behandlung von eingeschränktem blutkreislauf.
EP0301449A3 (en) Enantiomers of propafenone-containing therapeutic agents
IL87867A0 (en) Preparation of pharmaceutical compositions containing a 2,6-diamino-pyridine derivatives
AU1370188A (en) Tert.-butylamino-3-(phenyl-2'-phenoxy)-1-propanol-2 and its acid addition salts for use as an active therapeutic substance
UA13401C2 (uk) Ветеринарний препарат для профілактики та лікування хвороб вірусної та бактеріальної природи